Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/6155
Title: | Helicobacter pylori seropositivity in fibromyalgia syndrome [Article] | Authors: | Akkaya, Nuray Akkaya, S. Polat, Y. Turk, M. Turk, T. Turhal, E. Sahin, F. |
Keywords: | Fibromyalgia syndrome Helicobacter pylori extragastric manifestations Helicobacter pylori infection immunoglobulin A antibody immunoglobulin G antibody adult article controlled study disease association disease severity enzyme linked immunosorbent assay female fibromyalgia Helicobacter infection Helicobacter pylori human major clinical study priority journal questionnaire Adult Case-Control Studies Enzyme-Linked Immunosorbent Assay Female Fibromyalgia Helicobacter Infections Humans Immunoglobulin A Immunoglobulin G Inflammation Middle Aged Questionnaires Seroepidemiologic Studies Syndrome |
Abstract: | Although there are some studies suggesting relation between different types of infection and fibromyalgia syndrome (FM), there is presently no proof that FM is caused by an infection. Helicobacter pylori (HP) infection may cause extragastric manifestations. Inflammation is an important mediator of increased sympathetic nervous system activity and may lead to pain in fibromyalgia patients. In this study, we aimed to investigate the HP seropositivity in fibromyalgia patients compared with controls for possible role of HP infection in FM. Sixty-seven patients with fibromyalgia were evaluated. Two of them were excluded from the study because of high level of acute phase reactants. Sixty-five female patients with fibromyalgia and 41 randomly selected age-matched female healthy controls were enrolled to study. Serum HP IgA and IgG antibodies were measured by enzyme-linked immunosorbent assay technique. Fibromyalgia Impact Questionnaire was assessed in patients and controls. Seropositivity of HP IgG antibody in the fibromyalgia patients was significantly higher than in the control group. No statistically significant differences were found regarding the clinical features between fibromyalgia patients with HP IgG antibody and patients without IgG antibody. Our study suggests that former HP infection may have a role in the etiopathogenesis of fibromyalgia syndrome or may act as a triggering factor. However, high seroprevalence of HP in general population and prevalent asymptomatic infection make it difficult to interpret these results for the definite role of HP in FM. Highlighting the pathophysiologic mechanisms of FM will result in more effective treatment regimens. © Clinical Rheumatology 2010. | URI: | https://hdl.handle.net/11499/6155 https://doi.org/10.1007/s10067-010-1618-9 |
ISSN: | 0770-3198 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
SCOPUSTM
Citations
12
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
15
checked on Nov 21, 2024
Page view(s)
52
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.